Standard chemoradiation versus intensity-modulated chemoradiation: A quality of life assessment in oropharyngeal cancer patients

European Archives of Oto-Rhino-Laryngology

Volumn 267, Issue 7, 2010, Pages 1111-1116

  Mowry, Sarah E ^a   Tang, Christopher ^a   Sadeghi, Ahmad ^b   Wang, Marilene B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Chemoradiation; IMRT; Oropharyngeal cancer; Quality of life

Indexed keywords

CETUXIMAB; CISPLATIN; ETOPOSIDE; FLUOROURACIL;

ADVANCED CANCER; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MALE; MASTICATION; MOOD; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OROPHARYNX CARCINOMA; PATIENT ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RECREATION; SALIVA; SHOULDER; SPEECH; SWALLOWING; TASTE;

CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, INTENSITY-MODULATED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77955093638     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-009-1183-5     Document Type: Article

References (17)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) N Eng J Med 324(24):1685-1690.
2. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-staged oropharyngeal carcinoma. J Natl Cancer Inst 91(24):2081-2086.
3. Machtay M, Rosenthal DI, Hershock D, Jones H, Williamson S, Greenberg MJ et al (2002) Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 20(19):3964-3971.
4. Münter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, Rudat V et al (2007) Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys 67(3):651-659.
5. Lee NY, de Arrudo FF, Puri DR, Wolden SL, Narayana A, Mechaloakos J (2006) A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66(4):966-974.
6. Calais G, Bardet E, Sire C, Alfonsi M, Bourhis J, Rhein B et al (2004) Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial. Int J Radiat Oncol Biol Phys 58(1):161-166.
7. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME et al (2004) Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130(4):401-408.
8. Pourel N, Peiffert D, Lartigau E, Desandes E, Luporsi E, Conroy T (2002) Quality of life in long-term survivors of oropharynx carcinoma. Int J Radiation Oncology Biol Phys 54(3):742-751.
9. Ferlito A, Rogers SN, Shaha AR, Bradley PJ, Rinaldo A (2003) Quality of life in head and neck cancer. Acta Otolaryngol 123(1):5-7.
10. Mowry SE, Ho A, Lotempio MM, Sadeghi A, Blackwell KE, Wang MB (2006) Quality of life in advanced oropharyngeal carcinoma after chemoradiation versus surgery and radiation. Laryngoscope 116(9):1589-1593.
11. Braam PM, Terhaard CH, Roesink JM, Raaijmakers CP (2006) Intensity-modulated radiotherapy signiWcantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 66(4):975-980.
12. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A (2003) Quality of life after parotid-sparing IMRT for head-andneck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 57(1):61-70.
13. Yao M, Karnell LH, Funk GF, Lu H, Dornfeld K, Buatti JM (2007) Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 69(5):1354-1360.
14. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M et al (2005) Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 63(3):725-731.
15. Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJ et al (2007) Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 85(1):64-73.
16. Tschiesner U, Rogers SN, Harreus U, Berghaus A, Cieza A (2008) Content comparison of quality of life questionnaires used in head and neck cancer based on the international classification of functioning, disability and health: a systematic review. Eur Arch Otorhinolaryngol 265(6):627-637.
17. Borggreven PA, Verdonck-de Leeuw IM, Muller MJ, Heiligers ML, de Bree R, Aaronson NK, Leemans CR (2008) Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol 264(6):651-657.